This vax's success hinges on trust

India launches a single-dose HPV vaccine for 14-year-old girls to combat cervical cancer. This public health move faces skepticism due to safety concerns and past controversies. Building public trust through clear communication and robust safety checks is crucial for the vaccine's success, especially in rural areas. The government aims to prevent thousands of deaths annually.